[Federal Register Volume 73, Number 47 (Monday, March 10, 2008)]
[Notices]
[Page 12740]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-4754]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): ``Annual Estimates of Influenza Vaccine 
Effectiveness for Preventing Laboratory Confirmed Medically Attended 
Outcomes'', Funding Opportunity Announcement (FOA) IP08-001 and 
``Influenza Vaccine Efficacy in Tropical and Developing Countries'', 
FOA IP08-002

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 9 a.m.-5 p.m., April 30, 2008 (Closed).
    Place: Centers for Disease Control and Prevention, Atlanta, GA.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Annual Estimates of Influenza 
Vaccine Effectiveness for Preventing Laboratory Confirmed Medically 
Attended Outcomes'', Funding Opportunity Announcement (FOA) IP08-001 
and ``Influenza Vaccine Efficacy in Tropical and Developing 
Countries'', FOA IP08-002.''
    For Further Information Contact: Christine J. Morrison, Ph.D., 
Scientific Review Administrator, CDC, 1600 Clifton Road, NE., 
Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639-3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 29, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E8-4754 Filed 3-7-08; 8:45 am]
BILLING CODE 4163-18-P